 Estradiol
"Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
| Descriptor ID |
D004958
|
| MeSH Number(s) |
D04.210.500.365.415.248 D06.472.334.851.437.500
|
| Concept/Terms |
Estradiol- Estradiol
- Estradiol-17 beta
- Estradiol 17 beta
- Estradiol Anhydrous
- Oestradiol
- Estradiol-17beta
- Estradiol 17beta
- 17 beta-Estradiol
- 17 beta Estradiol
- 17 beta-Oestradiol
- 17 beta Oestradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Estradiol".
This graph shows the total number of publications written about "Estradiol" by people in this website by year, and whether "Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 2 | 5 | | 1997 | 2 | 3 | 5 | | 1998 | 2 | 4 | 6 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 4 | 8 | | 2001 | 4 | 4 | 8 | | 2002 | 6 | 4 | 10 | | 2003 | 9 | 4 | 13 | | 2004 | 2 | 2 | 4 | | 2005 | 6 | 5 | 11 | | 2006 | 6 | 7 | 13 | | 2007 | 9 | 8 | 17 | | 2008 | 8 | 11 | 19 | | 2009 | 5 | 8 | 13 | | 2010 | 10 | 5 | 15 | | 2011 | 5 | 8 | 13 | | 2012 | 6 | 9 | 15 | | 2013 | 8 | 7 | 15 | | 2014 | 5 | 7 | 12 | | 2015 | 9 | 8 | 17 | | 2016 | 7 | 4 | 11 | | 2017 | 6 | 9 | 15 | | 2018 | 6 | 7 | 13 | | 2019 | 6 | 5 | 11 | | 2020 | 6 | 6 | 12 | | 2021 | 5 | 5 | 10 | | 2022 | 0 | 7 | 7 | | 2023 | 2 | 10 | 12 | | 2024 | 4 | 2 | 6 | | 2025 | 8 | 4 | 12 | | 2026 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Estradiol" by people in Profiles.
-
van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Vosters TG, van Valkengoed IGM, Bjornstad P, Siegelaar SE, Nokoff NJ, den Heijer M, van Raalte DH. Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1070-e1079.
-
Shao C, Indeglia A, Foster M, Casey K, Leung J, Modarai SR, Leu JI, Duong B, Mes-Masson AM, Sims-Mourtada J, Auslander N, Drapkin R, Bitler BG, Zhang N, Murphy ME. Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. Genes Dev. 2026 Feb 02; 40(3-4):199-214.
-
Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. Alzheimers Dement. 2026 Feb; 22(2):e71067.
-
Misakian AL, Kelley CE, Sullivan EA, Chang JJ, Singh G, Kokosa S, Avila J, Cooper H, Liang JW, Botzheim B, Quint M, Jeevananthan A, Chi E, Harmer M, Hiatt L, Kowalewski M, Steinberg B, Tausinga T, Tanner H, Ho TF, Mark B, Zenger B, Hu S, Gebregzabheir A, Penny JM, Loeb DF, Strickland T, Iwamoto SJ, Rothman MS, Hamnvik OR, Ariel D. Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e2898-e2907.
-
Misakian AL, Ariel D, Sullivan EA, Singh G, Loeb D, Strickland T, Iwamoto SJ, Rothman MS, Botzheim B, Liang JW, Kelley C, Hamnvik OR. Injectable Estradiol Monotherapy Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy. Endocr Pract. 2025 Nov; 31(11):1462-1469.
-
Richey RE, Miner JA, Miner JC, Brunt VE, Kaplan PF, Halliwill JR, Minson CT. Exogenous estradiol increases cardiovagal baroreflex sensitivity during a hypertensive stimulus in premenopausal young women. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H439-H449.
-
Ogren AN, Zimmerman NJ, Stark S, McClellan M, Gonzalez SJ, Hartweck LM, Prins KW, Gardner MK. Estradiol pauses microtubule growth without increased incidence of catastrophe events. Commun Biol. 2025 Jun 18; 8(1):938.
-
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N. No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study. J Int AIDS Soc. 2025 May; 28(5):e26502.
-
Han AL, Vinod Paul K, Rao S, Brechbuhl HM, Sartorius CA, Ramachandran S, Kabos P. Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha. J Biol Chem. 2025 07; 301(7):108499.
-
Spritzer MD, Roy EA, Calhoun KMK, Schneider-Lynch ZE, Panella L, Michaelcheck C, Qian A, Kelly ED, Barr H, Hall E, Cunningham B, Nguyen HHM, Xu D, Barker JM, Galea LAM. Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male Rats. Biomolecules. 2025 04 07; 15(4).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|